FDA label
What is Iyuzeh used for?
Iyuzeh contains latanoprost. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “IYUZEH ™ (latanoprost ophthalmic solution) 0.005% is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted Iyuzeh?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Iyuzeh, solution/ drops
Indications and Usage, quoted from the label by Thea Pharma Inc. (NDA216472). Cross-references to other label sections are left out.
IYUZEH ™ (latanoprost ophthalmic solution) 0.005% is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.
Source: DailyMed label, set id 192fc081-cc38-4e83-b779-9592e060b915, version 7, effective July 30, 2024. NDC 82584-003, one of 1 listing for this product.
Questions
What is Iyuzeh used for?
The FDA label says: “IYUZEH ™ (latanoprost ophthalmic solution) 0.005% is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.”
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.